Literature DB >> 19494769

New insights into myocardial glucose metabolism: surviving under stress.

Brandy Patterson1, Anjali V Fields, Richard P Shannon.   

Abstract

PURPOSE OF REVIEW: Myocardial glucose uptake and metabolism are essential for maintaining myocardial energetics under circumstances of stress, such as myocardial ischemia or hypertrophy. We will discuss new information as to the mechanisms of altered glucose uptake as a consequence of impaired insulin action as well as emerging alternative cellular signaling mechanisms that lead to increased noninsulin dependent glucose uptake and metabolism. We will also review provocative clinical data that demonstrate the limitations of tight glycemic control as a mechanism to confer myocardial protection in patients with type 2 diabetes and discuss potential mechanistic explanations for the paradoxical results. RECENT
FINDINGS: New studies have shed important light on the distal mechanisms involved in insulin-mediated Glut 4 translocation. There are also important new insights into the role of AMP kinase and hypoxia-induced factor-1alpha in mediating myocardial glucose uptake while conferring cardioprotection.
SUMMARY: The importance of understanding the link between glucose uptake and cardioprotection is underscored by recent clinical trials that have failed to demonstrate a benefit between tight glycemic control and reduced cardiovascular events. These data underscore the need for additional agents that affect both outcomes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19494769     DOI: 10.1097/MCO.0b013e32832c4167

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  8 in total

Review 1.  A cardiologist's view of hypoglycemia.

Authors:  Shailesh Nandish; Jamison Wyatt; Rene Oliveros; Adrienne Stevens Zion; Michael Lujan; Robert Chilton
Journal:  Curr Atheroscler Rep       Date:  2010-03       Impact factor: 5.113

2.  Prolonged exposure to GH impairs insulin signaling in the heart.

Authors:  J G Miquet; J F Giani; C S Martinez; M C Muñoz; L González; A I Sotelo; R K Boparai; M M Masternak; A Bartke; F P Dominici; D Turyn
Journal:  J Mol Endocrinol       Date:  2011-08-30       Impact factor: 5.098

3.  Genetic manipulation of cardiac Hsp72 levels does not alter substrate metabolism but reveals insights into high-fat feeding-induced cardiac insulin resistance.

Authors:  Darren C Henstridge; E Estevez; T L Allen; S E Heywood; T Gardner; C Yang; N A Mellett; B A Kingwell; P J Meikle; M A Febbraio
Journal:  Cell Stress Chaperones       Date:  2015-01-25       Impact factor: 3.667

4.  Diabetes, muscles, and the myth of Ulysses' bow.

Authors:  Luigi Ferrucci; Stephanie Studenski
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

5.  α1A-Adrenergic receptor prevents cardiac ischemic damage through PKCδ/GLUT1/4-mediated glucose uptake.

Authors:  Ting Shi; Robert S Papay; Dianne M Perez
Journal:  J Recept Signal Transduct Res       Date:  2015-09-29       Impact factor: 2.092

6.  Effects of Selected Anionic β-Cyclodextrins on Persistence of Blood Glucose Lowering by Insulin Glargine after Subcutaneous Injection to Rats.

Authors:  Keiko Uehata; Takayuki Anno; Kayoko Hayashida; Keiichi Motoyama; Taishi Higashi; Fumitoshi Hirayama; Naomi Ono; James D Pipkin; Kaneto Uekama; Hidetoshi Arima
Journal:  J Drug Deliv       Date:  2011-12-11

7.  Intermittent hypoxia induces beneficial cardiovascular remodeling in left ventricular function of type 1 diabetic rat.

Authors:  Fırat Akat; Hakan Fıçıcılar; Ayşegül Durak; Erkan Tuncay; Ali Doğan Dursun; Ferda Topal Çelikkan; Bizden Sabuncuoğlu; Belma Turan; Metin Baştuğ
Journal:  Anatol J Cardiol       Date:  2018-04       Impact factor: 1.596

8.  Tsg101 Is Involved in the Sorting and Re-Distribution of Glucose Transporter-4 to the Sarcolemma Membrane of Cardiac Myocytes.

Authors:  Kobina Essandoh; Shan Deng; Xiaohong Wang; Yutian Li; Qianqian Li; Xingjiang Mu; Tianqing Peng; Guo-Chang Fan
Journal:  Cells       Date:  2020-08-21       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.